Nick’s practice is based in the broad field of the biosciences, with clients in the areas of biotechnology and medical devices. His expertise lies in immunology (in particular, antibodies/T cells), RNA interference, nanotechnology, recombinant DNA technology, diagnostics and microparticle technology.
His time is primarily focussed on prosecution and opposition matters at the European Patent Office. His experience and success in these areas means that he is often asked to deal with cutting edge and high profile cases. For example, he represented The Johns Hopkins University in the seminal case that set the 'plausibility' test for the amount of data required to support inventive step in a European patent (T1329/04).
Nick’s large and ever-growing client base spans UK companies, overseas attorneys and large multinationals. His passions include working with biotechnology companies, adding value by building strong and customised patent portfolios, designing and implementing patenting strategies and providing commercial and strategic advice on third party rights in due diligence exercises. He also provides advice directly to a number of US companies in the biosciences area, who highly value his expertise and ability to obtain and protect their European IP.
Nick has been recognised by The Legal 500 for his work representing Harvard College in its European patent for its gene editing technology CRISPR.
Nick is closely involved with smooth running of the firm and his skills extend to the management of many of Kilburn & Strode’s departments.
European Patent Attorney
Chartered UK Patent Attorney
IP Litigator - Patent
BSc Hons (Biochemistry) - University of Bristol
Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)
N. Bassil, K.Cornish, N. Lee, T. Leonard, Protecting the protector: The intersection of IP and Immuno-Oncology, Kilburn & Strode, (2019)